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Antibodies generated to a synthetic decapeptide, RMHLRQYELL, representing the carboxyl-terminus of Gs-ct have been 
characterized in immunoblots and functional studies. This antibody, designated RM, reacts exclusively with a doublet 
of proteins of 52 and 45 kDa in immunoblots ofbovine brain and wild-type $49 murine lymphoma cell membranes. 
No such reactivity is seen in membranes from cyc- $49 cells, which lack Gs. RM blocks receptor-mediated activation 
of Gs and adenylyl cyclase in membranes from wild-type $49 cells. RM could also immunoprecipitate ad nylyl cyclase 
activity in detergent extracts from GTP[),]S- or fluoride-preactivated bovine brain membranes; thus binding of cts to ef- 
fector and carboxyl-terminal antibody was mutually compatible. Such experiments provide an approach for the elucida- 
tion of functionally relevant interactions of G-proteins with receptors and effectors inthe membrane. 
GTP-binding protein; Adrenergic receptor, fl-; Adenylyl cyclase; Immunoprecipitation 
1. INTRODUCTION 
The central role in many transmembrane signal- 
ling pathways is occupied by one of a family of 
guanine nucleotide-binding proteins (G-proteins) 
[1-3]. This family comprises a group of structural- 
ly related heterotrimers of af?7 subunit composi- 
tion positioned at the cytoplasmic face of the 
membrane which transduce signals from activated 
receptors to specific effectors within the cell. The 
tr-subunits bind guanine nucleotides, possess 
GTPase activity and are targets for mono-ADP- 
ribosylation catalyzed by certain bacterial toxins. 
By virtue of their relatively divergent primary se- 
quence, the tr-subunits are believed to confer 
functional specificity to the oligomer. G-protein 
activation by specific receptors is characterized by 
binding of GTP in exchange for GDP and the con- 
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comitant dissociation of the ot-subunit from a 
tightly coupled ~'7 complex; dissociation allows 
one or both subunits to modulate target effectors. 
G-proteins mediate the effects of receptor activa- 
tion on enzyme function and ionic flux in many 
systems [1-3]. 
Our burgeoning knowledge of G-a protein se- 
quence predicted from cDNA and genomic loning 
studies [1-3] overshadows our understanding of 
the structural requirements which govern the 
specificity of interaction with effector and recep- 
tor. The carboxyl-terminal region of G-a was 
postulated to be involved in receptor coupling by 
Masters et al. [4] based on several lines of evi- 
dence. Homology of the tr-subunit of the retinal G- 
protein, transducin, with arrestin, the '48 kDa' 
protein of retina which competes with transducin 
for binding to photo-rhodopsin, is confined to the 
carboxyl-terminal region of c~-transducin [4,5]. 
Furthermore G-ct subunits which are functionall3/ 
uncoupled from receptors by pertussis toxin 
undergo a mono-ADP-ribosylation at a cysteine 
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residue four amino acids from the carboxyl- 
terminus [1-3]. More recently, a point mutation 
was identified in the genome of the unc  variant of 
$49 mouse lymphoma cells [6,7] which results in a 
Pro for Arg substitution six amino acids from the 
carboxyl-terminus of ces, and accounts for the un- 
coupling of receptor from Gs characteristic of this 
phenotype [8]. 
Less well defined are the domains of G-or which 
interact with and discriminate among effector 
molecules. A variable domain boundedby two 
highly conserved regions in the amino-terminal 
half of G-c~ was postulated by Masters et al. [4] to 
be involved in effector interaction. A comparable 
region has been implicated in effector signalling in 
the GTP-binding proteins EF-Tu [9] and p21 ras 
[10]. An elegant test of this model demonstrated, 
however, that a chimeric a-chain expressed from 
cDNA encoding the amino-terminal 60°7o f o'i and 
the carboxyl-terminal 40070 of as retained the effec- 
tor specificity expected of ors, stimulating adenylyl 
cyclase [11]. 
We describe here the development and charac- 
terization of antibodies to the carboxyl-terminal 
decapeptide of o~ as a probe of Gs function. These 
antibodies potently inhibit receptor-dependent ac- 
tivation of Gs in membranes. Antibody binding to 
this carboxyl-terminal domain is compatible with 
a's binding to and activation of effector, as demon- 
strated by the GTP [y]S-dependent immunoprecipi- 
tation of adenylyl cyclase activity. This approach 
promises to provide a means of identifying func- 
tionally relevant interaction of receptors and effec- 
tors with specific G-proteins in situ. 
2. MATERIALS AND METHODS 
2.1. Peptide synthesis, conjugation and immunization 
The decapeptide RMHLRQYELL was synthesized by the 
solid-phase method escribed by Barany and Merrifield [12] us- 
ing an Applied Biosystems 430A automated peptide synthesizer 
according to [13]. Conjugation of peptide to KLH according to 
Reichlin [14] and immunization of New Zealand White rabbits 
were performed as in [13,15]. 
2.2. Affinity purification of antibodies 
Affinity purification of antibodies to the decapeptide from 
crude antisera on a column of peptide covalently linked to 
agarose (Affigel 15, BioRad) was performed as described 
[13,15]. Prior to use, antibodies were exchanged into 150 mM 
NaC1/50 mM Tris-HC1 (pH 7.5) by gel filtration in Sephadex 
G-25 M (PD-10 prepacked columns, Pharmacia). Concentra- 
tion of affinity-purified antibodies and normal rabbit immuno- 
globulin (Pel-Freez) was determined spectrophotometrically 
using the relation A278(1070) = 13.8 [16], assuming a molecular 
mass of 150000 g/mol for immunoglobulin. 
2.3. Membrane preparations 
Membranes of bovine brain were prepared according to 
Sternweis and Robishaw [17]. Membranes from wild-type and 
cyc- $49 murine lymphoma cells were prepared as described 
[18]. Membranes were stored under liquid N2 until use. After 
thawing all subsequent s eps were performed at 0-4°C unless 
otherwise indicated. 
2.4. Antibody treatment of membranes 
Membrane aiiquots (3-6.5 mg/ml) were thawed and diluted 
with 4 vols ice-cold 150 mM NaC1/10 mM MgClg20 mM Tris- 
HCI (pH 7.5) (NMT) buffer. After centrifugation at 48000 × g 
for 30 min, the supernatant was discarded and the membrane 
pellet resuspended in 1 vol. NMT. Normal rabbit immuno- 
globulin or affinity-purified RM antibodies were added in 
1/20-1/10 vol. to a final concentration f 1-100/zg/ml. When 
the concentration dependence of RM antibody effects was being 
examined, serial dilutions were made into a solution of normal 
rabbit immunoglobulin to keep total immunoglobulin concen- 
tration constant. After incubation for 2 h at 4°C, 30-/A aiiquots 
were assayed for adenylyl cyclase activity as described below. 
2.5. lmmunoprecipitation 
Membranes (3-6.5 mg/ml) were thawed and diluted with 
4 vols ice-cold NMT. After centrifugation at 48000 × g for 
30 min, the membrane pellet was resuspended in 1 vol. NMT. 
Membranes were incubated for 20 min at 30°C, with or without 
100/zM GTP[7]S or 10 mM NaF as indicated in the figure 
legends. They were then chilled on ice, and recentrifuged as
before. The supernatant fractions were discarded, and the 
membranes resuspended in 1 vol. NMT. An equal volume of 
2070 (w/v) C12E9 Lubrol (Sigma P-9641) in NMT was added, 
and after brief mixing, the sample was incubated on ice for 
30-60 min. The insoluble material was removed by centrifuga- 
tion, and the supernatant representing the detergent extract 
(2-3 mg/ml in protein) was recovered. Control or affinity- 
purified RM antibody was then added in 1/20 or 1/10 vol. to 
a final concentration of 20-100/~g/ml, and the samples in- 
cubated for 4 h at 4°C. Immunoprecipitation was effected by 
addition of Staphylococcus aureus cells [Pansorbin, Calbio- 
chem; cells previously exchanged into 107o (w/v) C12E9 Lubrol 
in NMT by centrifugation; 1/~1 of 10070 (w/v) suspension added 
per/~g IgG], incubation for 30 min at 4°C and centrifugation in 
a Beckman microfuge. The supernatant fraction was carefully 
removed, and the pellet washed once, then resuspended to the 
original volume with 1070 (w/v) C12E9 Lubrol in NMT con- 
taining 3-5 mg/ml bovine serum albumin as carrier. Aliquots 
(30/A) of the unfractionated detergent extract containing an- 
tibody (total) and the resuspended immunoprecipitate (p llet) 
were assayed for adenylyl cyclase activity, as described below, 
or analyzed for Oes content by SDS-PAGE and immunoblotting 
with RM antibodies ( ee below). 
2.6. Adenylyl cyclase assays 
Adenylyl cyclase activity in 30-40/zl membrane suspension 
and/or detergent extract, prepared as above, was determined in 
100/zl final assay volume which contained in addition 0.1 mM 
[oe-32p]ATP (2-5 × 106 cpm), 1 mM dithiothreitol, 0.2 mg/ml 
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creatinine phosphokinase, 1.8 mg/mt creatine phosphate, 
20/~M cAMP, 10 mM MgC12 and 30 mM Tris-HCl (pH 7.5). 
Samples from bovine brain included 1 mM isobutylxanthine 
(Fluka). Other components when present included NaF, GTP, 
GTP[-r]S, forskolin, and (-)-isoproterenol atfinal concentra- 
tions of 10 mM, 100/~M, 100/~M, 100/~M and 500/zM, respec- 
tively. Reactions were carried out at 30°C for 20 min, and 
terminated by addition of carrier ATP and [3H]cAMP. 
Radiolabeled cAMP was isolated by the method of Salomon et 
al. [19] as described in [20]. 
2.7. SDS-PAGE and immunoblotting 
These procedures were performed asin [15,21]. Immunoblots 
of detergent extracts containing antibody or subfractions 
generated by immunoprecipitation used [125I]iodo-recombinant 
protein A (New England Nuclear, NEX 146-L; 0.2-0.5/~Ci/ml) 
in place of secondary antibody, followed by autoradiography 
for 1-6 days in Kodak X-Omatic assettes with regular intensi- 
fying screens at -70°C. 
3. RESULTS 
Antisera were generated in two rabbits against 
the synthetic decapeptide, RMHLRQYELL,  cor- 
responding to the carboxyl-terminal of trs pre- 
dicted from cDNA sequences in several species 
[22-27]. Attention was directed to this region 
because of its possible role in coupling to receptors 
(see above) and because of the success of previous 
antisera developed against the carboxyl-terminal 
decapeptides of transducin-tr [13,28] and Go-t~ 
[29]. Immune sera from both rabbits, designated 
RM/ I  and RM/2, but not preimmune sera, iden- 
tified a doublet of 45 and 52 kDa on immunoblots 
of proteins in a cholate extract of bovine brain 
membranes. Affinity purification of antibodies on 
a column of immobilized peptide-agarose g ner- 
ated a reagent (RM antibody) which identified only 
the 45 and 52 kDa doublet in bovine brain mem- 
branes and membranes from wild-type $49 murine 
lymphoma ceils (fig.l). This reactivity could be 
blocked by coincubation with low concentrations 
of free peptide (not shown). In contrast, no reac- 
tivity was seen in membranes from cyc- $49 cells 
[30], which lack mRNA corresponding to Gs-te [31] 
(fig.l, lane 3). These findings demonstrate the 
specific reactivity of the anti-peptide antibodies 
with both of the major size classes of as identified 
by protein purification [32] and cDNA cloning 
[22-27]. 
Because the carboxyl-terminus of several Goe 
subunits is accessible in membranes to pertussis 
toxin [1-3], we reasoned that RM might recognize 
Gs in native membranes as well, with possible func- 
Fig.l. Immunoblotting of Gs-c~ with RM antibody. Membrane 
samples of bovine brain (lane 1, 50/~g), wild-type $49 murine 
lymphoma cells (lane 2, 100/@g) or cyc- $49 cells (lane 3, 
100/zg) were separated in 10% polyacrylamide g lby SDS- 
PAGE, and after transfer to nitrocellulose immunoblotted with 
affinity-purified RM antibody at 10/Lg/ml. Molecular masses 
(in kDa) of marker proteins and Gs-te subunits, and position of 
dye front (DF) are indicated to the left. Note minor cross- 
reacting species at -75 kDa in lanes 2,3. 
tional effects. $49 murine lymphoma cells which 
possess ~-adrenergic receptors coupled to adenylyl 
cyclase via Gs (see [33]) were used to examine the 
functional consequences of RM treatment. Iso- 
proterenol-dependent activation of Gs mediated by 
the fl-adrenergic receptor was inhibited by RM in 
a concentration-dependent fashion in membranes 
of wild-type $49 murine lymphoma cells with an 
ICs0 value of approx. 25 nM (fig.2). Receptor- 
independent activation of Gs by fluoride [34] was 
also inhibited by RM. Such inhibition was much 
weaker, however, as antibody concentrations upto 
0.25/~M (38/~g/ml) produced only a 30°7o inhibi- 
tion of fluoride stimulation in $49 cell membranes 
(fig.2). All of the inhibitory effects of RM on Gs 
function in $49 cells could be prevented by coin- 
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Fig.2. Concentration dependence of RM antibody inhibition of 
isoproterenol and fluoride activation of G,. Wild-type $49 cell 
membranes were incubated with increasing amounts of RM 
antibody for 2 h at 4°C as shown, after which aliquots were 
assayed for adenylyl cyclase activity with 10 mM NaF (o), or 
with 100/~M GTP with (e) or without (&) 500/~M ( - ) -  
isoproterenol. Control values (10007o) (in pmol cAMP/min per 
mg) were 84 (o) and 60 (e, A). Values represent means of 
triplicate determinations. 
cubation with the cognate peptide (not shown). In 
contrast to the results in $49 cell membranes, RM 
inhibited fl-adrenergic and fluoride-activated 
cyclase activity with similar efficacy in turkey 
erythrocyte membranes (not shown). 
The mutual compatibility of o~s interaction with 
RM and effector was studied in detergent extracts 
of bovine brain membranes pretreated with 
GTP[7]S. Such pretreatment promotes persistent 
activation of adenylyl cyclase, whether measured 
in the membranes or in the subsequent detergent 
extract, presumably mediated by a stable ~s- 
GTP[7]S complex. Incubation of detergent extract 
from preactivated membranes with RM (19-91 
/~g/ml) produced a variable inhibition of adenylyl 
cyclase activity (23-50%) relative to extract 
incubated with the equivalent amount of normal 
rabbit immunoglobulin ( ot shown). Immunopre- 
cipitation of immunoglobulins with protein A 
(Pansorbin S. aureus cells) significantly depleted 
cyclase activity in extracts incubated with RM 
(35-81°70, n = 9), but not in those with normal 
IgG. This cyclase activity could be recovered in the 
RM immunoprecipitates upon resuspension 
(fig.3). No such activity could be recovered in nor- 
mal IgG immunoprecipitates or RM immunopre- 
cipitates from extracts lacking GTP[7]S preacti- 
vation (fig.3). Parallel immunoblotting revealed 
comparable immunoprecipitation f ors by RM 
with or without preactivation (fig.3, inset). Preac- 
tivation of brain membranes with fluoride in place 
of GTP[7]S gave comparable r sults (not shown). 
4. DISCUSSION 
An outstanding problem in our understanding 
of signal transduction by G-proteins is the struc- 
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Fig.3. Immunoprecipitation of adenylyl cyclase activity and as 
by RM antibody. Detergent extracts were prepared from bovine 
brain membranes with or without preactivation by 100#M 
GTP[7]S for 20 min at 30°C, as described in section 2. Extracts 
(3 mg/ml) were incubated with normal immunoglobulin or RM 
antibody (50/~g/ml; 0.33/~M) for 4 h at 4°C, following which 
immunoprecipitation was initiated by addition of protein A S. 
aureus  cells (Pansorbin). After centrifugation, the supernatant 
was removed and the pellet washed then resuspended in 
detergent buffer. Adenylyl cyclase activity was determined on 
20-/L1 aliquots from each fraction. Assays included 100/~M 
GTP[7]S, 1 mM isobutylmethylxanthine, and 1 mg/ml BSA. 
Activity in the pellets (immunoprecipitates) is hown. (A,B) No 
preactivation; (C,D) GTP[7]S preactivation of membranes. 
(A,C) Normal immunoglobulin; (B,D) RM antibody. Activity 
recovered in pellet D represented approx. 25°70 of total starting 
activity in the extract containing RM antibody. (Inset) Parallel 
immunoblot analysis of ors content in pellets generated by 
immunoprecipitation. (A-D) As indicated above. Recovery of 
both forms of a~ in pellets B,D was approx. 30070 of the o~s 
present in starting material as estimated by densitometry. 
Immunoblot developed with RM antibody at 10/~g/ml, 
followed by [125I]iodo-protein A. Position of 52 and 45 kDa 
forms of o~s indicated. 
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tural basis for the specificity required to discrimi- 
nate among various receptors and effectors in the 
membrane. While little is known about the reper- 
toire of 7-subunits present in G-protein 
heterotrimers, only two forms of fl-subunit have 
been identified which are 90070 homologous 
[35,36]. Thus, the more variable ce-subunits must 
in large part provide the requisite structural 
specificity to ensure fidelity in signal transduction. 
Indeed, the resolved a-subunits are necessary and 
sufficient for stimulation of effectors including 
adenylyl cyclase [37] and cGMP phosphodiesterase 
I38]. 
We present here the characterization f a site- 
specific probe of Gs function, an antibody to the 
decapeptide comprising the carboxyl-terminus of 
as. This extreme carboxyl-terminal region of the 
G~,-subunit may play a role in receptor interaction 
as postulated by Masters et al. [4] based on 
evidence cited above. Furthermore, Cerione et al. 
[28] have recently shown that antibodies to the 
comparable region of transducin~ block the in- 
teraction of holotransducin with the photoreceptor 
rhodopsin in reconstituted phospholipid vesicles. 
Interest in this region was further heightened by 
the finding that the domain governing effector 
specificity may also reside in the carboxyl-terminal 
40°70 of G~ [11]. Highly selective reagents for a'il 
and a'i2 [13] and for ao [29] have been previously 
generated exploiting carboxyl-terminal sequence 
divergence for the development of antibodies to 
synthetic peptides. 
As the C-terminal decapeptide s quence of as is 
relatively divergent from other G~s, it was not 
unexpected that RM proved highly selective for the 
two forms of as. When several tissues were tested 
on immunoblots, no evidence of cross-reactivity 
with more abundant G-proteins, such as Go, Gil 
and Gi2 in bovine brain and Gi2 and Gi3 in $49 
cells, was observed. Recent experiments with a 
panel of soluble recombinant G~ subunits in E. coli 
lysates howed that RM uniquely immunoprecipi- 
tated as (unpublished). 
RM potently inhibited the Gs-mediated fl- 
adrenergic stimulation of adenylyl cyclase. This 
finding supports the view that the carboxyl- 
terminus of G~ is essential for interaction with 
receptor [4] and parallels observations with an- 
tibodies (AS/7) to the C-terminus of transducin-a 
which blocked its activation by photorhodopsin 
[28]. The same AS/7 antibody was found to block 
opioid receptor, but not serum-stimulated GTPase 
in NG108-15 cell membranes [39]. RM thus un- 
couples Gs from receptor, producing a state 
resembling the unc $49 mutant phenotype in this 
regard. 
The inhibition seen to direct activation of Gs by 
fluoride was unexpected, suggesting antibody ef- 
fects are more generalized than other 'uncoupling' 
lesions involving the extreme G~ C-terminus, such 
as the Arg 3s9 to Pro mutation in unc $49 Gsa [6,7] 
or ADP-ribosylation by pertussis toxin of ai and 
ao [1-3]. In the case of the latter modifications, 
AIF~ or GTP[7]S can still activate the G-protein 
involved as demonstrated bysubunit dissociation, 
effector activation or stabilization to tryptic diges- 
tion. If conformational change in this C-terminal 
domain of G~ plays an essential part in the con- 
certed or sequential exchange of guanine nucleo- 
tide and dissociation of/37, then antibody binding 
could dampen or sterically hinder such motion, 
producing a 'global' inhibition. ADP-ribosylation 
or the unc mutation might preclude receptor 
binding without impairing the overall mobility of 
this region. The marked ifference in sensitivity to 
RM of receptor-mediated and fluoride activation 
of Gs in $49 cell membranes is consistent with dual 
mechanisms of inhibition. 
Immunoprecipitation of adenylyl cyclase activi- 
ty by RM was dependent on preactivation of Gs 
with GTP[7]S or fluoride. In contrast, RM im- 
munoprecipitated as regardless of the state of ac- 
tivation. The potential stability of the interaction 
between ~s and the catalytic omponent of ade- 
nylyl cyclase has been noted by others who de- 
scribed comigration of the two during affinity 
purification of the catalyst [40,41]. The stability to 
RM immunoprecipitation of an ~s-cyclase complex 
may prove indicative of the strength of interaction 
of ~s with other putative ffector molecules [42]. 
The ability of RM to bind to an activated as- 
effector complex suggests that the extreme C- 
terminal decapeptide r gion does not figure criti- 
cally in the putative ffector interaction domain of 
the G~ subunit [11]. 
The experiments described here offer a means of 
targeting the functional interaction of specific G- 
proteins with receptors and effectors using G~ 
carboxyl-terminal ntibodies. This approach is 
unique in that antibodies of predefined specificity 
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which recognize domains in native G-proteins in 
the membrane and which can precipitate active G~- 
effector complexes are employed to obtain infor- 
mation on functional interaction. Specific an- 
tibodies against synthetic peptides comprising G~ 
domains may allow unequivocal assignment of 
function to a particular G-protein, even in complex 
biological membranes xpressing a multiplicity of 
receptors, G-proteins and effectors. Reconstitu- 
tion and transfection experiments involving G- 
proteins, receptors and effectors evaluate the 
potential for interaction among components atan 
experimentally defined stoichiometry, but do not 
address the question of their endogenous roles. 
With a clear definition of the relevant functional 
interactions will come an understanding of the 
structural features governing the discrimination re- 
quired of signal-transducing G-proteins. 
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